Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Lallemant

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Journal of Clinical Medicine|May 13, 2023
Enteral Nutrition during Radiotherapy for Oropharyngeal Cancers: Prevalence and Prognostic Factors Based on HPV Status (A GETTEC Study)Dorian Culié, Renaud Schiappa, Tanguy Pace-Loscos, et al.
British Journal of Clinical Pharmacology|February 28, 2019
Cetuximab pharmacokinetic/pharmacodynamics relationships in advanced head and neck carcinoma patientsFélicien Le Louedec, Catherine Alix-Panabières, Thierry Lafont, et al.
Substance Use & Misuse|August 8, 2013
Feasibility and Efficacy of an Addiction Treatment Program in Patients With Upper Aerodigestive Tract CancerPascal Perney, Yohan Duny, Bertrand Nalpas, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 7, 2018
Impact of HPV-associated p16-expression and other clinical factors on therapeutic decision-making in patients with oropharyngeal cancer: A GETTEC multicentric studyDorian Culié, Renaud Garrel, Julien Viotti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2020
Equivalence Randomized Trial to Compare Treatment on the Basis of Sentinel Node Biopsy Versus Neck Node Dissection in Operable T1-T2N0 Oral and Oropharyngeal CancerRenaud Garrel, Gilles Poissonnet, Antoine Moyà Plana, et al.
Oral Oncology|September 9, 2021
Metachronous second primary neoplasia in oropharyngeal cancer patients: Impact of tumor HPV status. A GETTEC multicentric studyFlorent Milliet, Alexandre Bozec, Renaud Schiappa, et al.
Oral Oncology|October 31, 2020
Synchronous primary neoplasia in patients with oropharyngeal cancer: Impact of tumor HPV status. A GETTEC multicentric studyFlorent Milliet, Alexandre Bozec, Renaud Schiappa, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 2, 2020
Upfront surgery or definitive radiotherapy for patients with p16-negative oropharyngeal squamous cell carcinoma. A GETTEC multicentric studyDorian Culié, Julien Viotti, Anouchka Modesto, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 4, 2021
Upfront surgery or definitive radiotherapy for p16+ oropharyngeal cancer. A GETTEC multicentric studyDorian Culié, Renaud Schiappa, Anouchka Modesto, et al.
European Journal of Cancer (Oxford, England : 1990)|December 17, 2020
Oropharyngeal cancer: First relapse description and prognostic factor of salvage treatment according to p16 status, a GETTEC multicentric studyDorian Culié, Quentin Lisan, Charlotte Leroy, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Journal of Clinical Medicine|May 13, 2023
Enteral Nutrition during Radiotherapy for Oropharyngeal Cancers: Prevalence and Prognostic Factors Based on HPV Status (A GETTEC Study)Dorian Culié, Renaud Schiappa, Tanguy Pace-Loscos, et al.
British Journal of Clinical Pharmacology|February 28, 2019
Cetuximab pharmacokinetic/pharmacodynamics relationships in advanced head and neck carcinoma patientsFélicien Le Louedec, Catherine Alix-Panabières, Thierry Lafont, et al.
Substance Use & Misuse|August 8, 2013
Feasibility and Efficacy of an Addiction Treatment Program in Patients With Upper Aerodigestive Tract CancerPascal Perney, Yohan Duny, Bertrand Nalpas, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 7, 2018
Impact of HPV-associated p16-expression and other clinical factors on therapeutic decision-making in patients with oropharyngeal cancer: A GETTEC multicentric studyDorian Culié, Renaud Garrel, Julien Viotti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2020
Equivalence Randomized Trial to Compare Treatment on the Basis of Sentinel Node Biopsy Versus Neck Node Dissection in Operable T1-T2N0 Oral and Oropharyngeal CancerRenaud Garrel, Gilles Poissonnet, Antoine Moyà Plana, et al.
Oral Oncology|September 9, 2021
Metachronous second primary neoplasia in oropharyngeal cancer patients: Impact of tumor HPV status. A GETTEC multicentric studyFlorent Milliet, Alexandre Bozec, Renaud Schiappa, et al.
Oral Oncology|October 31, 2020
Synchronous primary neoplasia in patients with oropharyngeal cancer: Impact of tumor HPV status. A GETTEC multicentric studyFlorent Milliet, Alexandre Bozec, Renaud Schiappa, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 2, 2020
Upfront surgery or definitive radiotherapy for patients with p16-negative oropharyngeal squamous cell carcinoma. A GETTEC multicentric studyDorian Culié, Julien Viotti, Anouchka Modesto, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 4, 2021
Upfront surgery or definitive radiotherapy for p16+ oropharyngeal cancer. A GETTEC multicentric studyDorian Culié, Renaud Schiappa, Anouchka Modesto, et al.
European Journal of Cancer (Oxford, England : 1990)|December 17, 2020
Oropharyngeal cancer: First relapse description and prognostic factor of salvage treatment according to p16 status, a GETTEC multicentric studyDorian Culié, Quentin Lisan, Charlotte Leroy, et al.
Pageof 4